Vivanza Biosciences

BSE: 530057 29 Jul 2025

Healthcare

₹ 2.07

Vivanza Biosciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Vivanza Biosciences

BSE: 530057 29 Jul 2025

Healthcare

₹ 2.07

Vivanza Biosciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Book Value

1.0

Dividend Yield

0.0%

Debt to Equity

1.52

Stock P/E

Market Cap

9.48 Cr

Vivanza Biosciences - Share Price & Details

Market Cap

₹9.48

High /Low

6.09 / 1.9

Stock P/E

Book Value

₹1.0

Dividend Yield

0.0

ROCE

-3.76

ROE

₹-16.0

Face Value

1.0

PEG Ratio

EVEBITDA

₹-47.1

Debt

6.10

CMP / FCF

-49.0

Debt to equity

₹1.52

NP Ann

-0.70

High price all time

21.0

Piotroski score

₹1.0

Graham Number

No. Eq. Shares

4.0

Net CF

₹-0.04

Net profit

-0.70

Price to book value

2.36

Interest Coverage

₹-0.97

Low price all time

0.44

Industry PE

33.8

Reserves

₹0.02

Free Cash Flow

₹-2.48

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.46	91.0
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
Vivanza Biosciences Limited	5.29	-9.98	4.83	-0.25	9.48
DR LALCHANDANI LABS LIMITED	NA	NA	NA	NA	8.92	21.2
DHANVANTRI JEEVAN REKHA LTD.	59.40	0.30	58.30	0.45	8.71	17.1

Peer Comparison Chart

About Vivanza Biosciences

Vivanza Biosciences Limited, with Security Code 530057, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Minerals Inc. stock price move sharply - Invest smarter with daily stock recommendations

(28 Jul 2025)

【Growth Stocks】✌️ Receive daily stock suggestions and forecasts for better investment timing.

AstraZeneca Pharma India Limited (506820) Expands into New Market - Game-changing returns

(26 Jul 2025)

【Market Focus】✌️ Not just predictions — our stock selections are backed by real-time data and proven track records of 2x–3x growth.

Rajshree Polypack Limited (RPPL) Hits 52 Week High - Free Investment Case Studies

(26 Jul 2025)

【Market Focus】✌️ Stay informed on global stock trends, earnings surprises, and breakout patterns that have helped investors realize 200%+...

Artelo Biosciences Inc. Stock Analysis and Forecast - Free Wealth Planning Blueprint

(25 Jul 2025)

【Stock Buzz】✌️ Our daily recommendations come with performance histories — many of which show over 200% ROI within 6–12 months.

Does Noah Holdings Limited Depositary Receipt stock pay reliable dividends - Free Stock Market Real-Time Monitoring

(25 Jul 2025)

【Trading Ideas】✌️ Plan your next investment move with reliable market intelligence.

Is Vivanza Biosciences Limited (530057) a Good Long Term Bet - Outstanding trading profits

(25 Jul 2025)

Is Vivanza Biosciences Limited (530057) a Good Long Term Bet ✌️【Stock Buzz】✌️ Benefit from personalized investment strategies designed to...

Quarterly Table

Standalone Consolidated

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	1.0	4.8	6.0	4.9	3.9	3.4	2.3	0.4	1.6	0.8
Expenses	1.0	4.3	6.0	4.5	3.6	3.1	2.4	0.1	1.5	0.6
Operating Profit	0.0	0.5	0.0	0.4	0.2	0.3	-0.1	0.3	0.1	0.1
OPM %	1.05%	10.81%	0.75%	8.7%	6.3%	7.96%	-5.87%	74.53%	6.25%	15.62%
Other Income	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.1	0.4	0.1	0.3	0.2	0.2	-0.3	0.2	0.0	0.0
Tax %	0%	0%	-187.3%	0%	0%	0%	41.9%	0%	0%	0%
Net Profit	0.1	0.4	-0.1	0.3	0.2	0.2	-0.4	0.2	0.0	0.0
EPS in Rs	0.37	1.04	-0.14	0.01	0.05	0.01	-0.09	0.06		0.01

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	5.9	8.2	9.2	7.6	6.6	4.4	2.4	3.0	1.5	0.5
Expenses	5.3	8.2	8.6	7.3	6.3	4.6	2.1	2.9	1.4	1.4
Operating Profit	0.6	0.0	0.6	0.3	0.3	-0.1	0.4	0.1	0.1	-0.9
OPM %	9.56%	-0.04%	6.42%	4.19%	4.45%	-3.03%	14.68%	3.67%	8.33%	-193.37%
Other Income	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.5	0.0	0.5	0.3	0.2	-0.3	0.3	0.0	0.0	-1.0
Tax %	0%	-786.7%	0%	0%	0%	55.6%	0%	0%	0%	0%
Net Profit	0.5	-0.1	0.5	0.3	0.2	-0.4	0.3	0.0	0.0	-1.0
EPS in Rs	1.15	-0.26	0.12	0.07	0.01	-0.1	0.07		0.01	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	-21%
3 Years:	-31%
TTM:	-80%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-319%

Stock Price CAGR
10 Years:	15%
5 Years:	0%
3 Years:	-47%
1 Year:	-61%

Compounded Sales Growth
10 Years:	0%
5 Years:	-5%
3 Years:	-11%
TTM:	-73%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-222%

Stock Price CAGR
10 Years:	15%
5 Years:	0%
3 Years:	-47%
1 Year:	-61%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Vivanza Biosciences

Vivanza Biosciences

Vivanza Biosciences - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Vivanza Biosciences

Latest News

Minerals Inc. stock price move sharply - Invest smarter with daily stock recommendations

AstraZeneca Pharma India Limited (506820) Expands into New Market - Game-changing returns

Rajshree Polypack Limited (RPPL) Hits 52 Week High - Free Investment Case Studies

Artelo Biosciences Inc. Stock Analysis and Forecast - Free Wealth Planning Blueprint

Does Noah Holdings Limited Depositary Receipt stock pay reliable dividends - Free Stock Market Real-Time Monitoring

Is Vivanza Biosciences Limited (530057) a Good Long Term Bet - Outstanding trading profits

Vivanza Biosciences Limited (530057) Announces Strategic Shift - Superior portfolio returns

What drives Ring Energy Inc. stock price - Remarkably fast returns

Ken Financial Services Limited (530547) Gets Regulatory Approval - Explosive trading opportunities

Vivanza Biosciences Limited (530057) Sees Unusual Trading Volume - Explosive earnings growth

Vivanza Biosciences Limited (530057)’s Trend in 2025 - Free Investment Case Studies

Vivanza Biosciences Limited (530057)’s Trend in 2025 - Massive stock growth

What drives SB.PRD stock price - Rapid growth trajectories

Technical Analysis: Skipper Limited (SKIPPERPP) - Accelerated investment success

Technical Analysis: Sumitomo Chemical India Limited (542920) - Explosive earning power

India Best Stocks for Small Investors High Growth Investment Options - Superior returns

Vivanza Biosciences Limited (530057) Signs Major Deal - Skyrocketing investment returns

Vivanza Biosciences Limited (530057) Stock Experiences Sudden Dip - High-velocity gains

Vivanza Biosciences Limited (530057)’s Trend in 2025 - Massive wealth growth

Vivanza Biosciences Limited (530057)’s Trend in 2025 - Free Stock Selection

Vivanza Biosciences Limited (530057) Stock Experiences Sudden Dip - Free Capital Allocation Plans

Vivanza Biosciences Limited (530057) Signs Major Deal - Dynamic profit expansion

How to Capitalize on India’s Economic Growth Through Stocks Investment Portfolio Booster - Skyrocketing profit margins

Bullish Pattern Emerging on Vivanza Biosciences Limited (530057) - Exceptional market performance

Analyzing the Best Performing IPOs in Stock Market Intelligent Investment Decisions - High-margin investment plays

Is Vivanza Biosciences Limited (530057) a Good Long Term Bet - Exceptional trading performance

Vivanza Biosciences Limited (530057) Sees Unusual Trading Volume - Rapidly growing investment returns

Stocks with Rising Popularity in India AI Backed Financial Forecasting - Outstanding stock performance

Naksh Precious Metals Limited (539402) Expands into New Market - Overwhelming financial success

Technical Analysis: Vivanza Biosciences Limited (530057) - Consistent triple-digit returns

Technical Analysis: Vivanza Biosciences Limited (530057) - Consistent high-performance stocks

Wabash National Corporation Stock Analysis and Forecast - Outstanding trading profits

Best AI Stocks Expert Selected Market Trends - Triple-digit returns

Best Stocks for Inflation Hedge Premium Investor Club Insights - Outstanding trading profits

Top Performing Stocks on the NSE in India Premium Stock Insights - Explosive trading opportunities

Best Dividend Growth Stocks in India Premium Stock Trading Group - Explosive earning power

Is Vivanza Biosciences Limited (530057) a Good Long Term Bet - Unstoppable profit momentum

Vivanza Biosciences Limited (530057)’s Trend in 2025 - Free Predictions

Published on: 2025-07-19 09:21:13

Is Kelly Services Inc. a good long term investment - Outstanding trading profits

Vivanza Biosciences Faces Intense Selling Pressure Amid Significant Price Declines

Krishna Institute of Medical Sciences consolidated net profit rises 55.42% in the March 2025 quarter

Tata Steel consolidated net profit rises 112.73% in the March 2025 quarter

Prudent Corporate Advisory Services consolidated net profit rises 16.09% in the March 2025 quarter

Share Market Today | Latest Stock Market News, Sensex Today and Nifty Live Updates

Vivanza Biosciences Reports Significant Operational Challenges in March 2025 Financial Results

Vivanza Bio Standalone March 2025 Net Sales at Rs 0.17 crore, down 92.62% Y-o-Y

Vivanza Bio Consolidated March 2025 Net Sales at Rs 0.48 crore, down 89.08% Y-o-Y

Arco Leasing reports consolidated net loss of Rs 0.04 crore in the March 2025 quarter

Board Meeting Outcome for Outcome Of Board Meeting Held Today 12Th May 2025

VIVANZA BIOSCIENCES ANNOUNCES BOARD MEETING DATE

Sellwin Traders consolidated net profit rises 42.86% in the March 2025 quarter

Q4 Results Today: Tata Steel, Raymond, PVR Inox, Ather Energy Among 80 Firms To Declare Earnings On May 12

Q4 Results 2025 Today, May 12: Tata Steel, SRF, UPL, PVR Inox among 80 NSE, BSE companies to declare quarterly earnings

Q4 results: Tata Steel, Raymond, SRF, Ather Energy, PVR Inox, UPL, others to declare earnings on May 12; check list

Vivanza Biosciences to hold board meeting

Vivanza Biosciences Hits All-Time Low Amidst Ongoing Financial Challenges and Declining Stakeholder Confidence

Vivanza Biosciences Hits 52-Week Low Amid Ongoing Financial Challenges and Stakeholder Concerns

Vivanza Biosciences Faces Challenges Amid Significant Stock Decline and Weak Fundamentals

Vivanza Biosciences Faces Major Financial Challenges Amidst Declining Stakeholder Confidence

Vivanza Biosciences Hits All-Time Low Amid Ongoing Financial Struggles and Volatility

Vivanza Biosciences reports consolidated net loss of Rs 1.00 crore in the March 2025 quarter

Godrej Agrovet consolidated net profit rises 21.40% in the December 2024 quarter

Sensex falls! But these stocks gained over 10% on BSE

Sensex falls! These stocks are down 5% or more on BSE

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

Vivanza Biosciences Hits 52-Week Low at Rs. 3.21 Amid Ongoing Decline

Ten stocks close to their 52-week low

Bulk Deals | Buyer | Seller | BSE | NSE | Stock as on Nov 16, 2024

Bulk Deals | Buyer | Seller | BSE | NSE | Stock as on Nov 19, 2024

Bulk Deals | Buyer | Seller | BSE | NSE | Stock as on Nov 11, 2024